OpenAI and Anthropic Move Toward IPOs, Accelerating AI Expansion in Healthcare

OpenAI and Anthropic, two of the leading companies in artificial intelligence, have formally taken steps toward initial public offerings (IPOs) while accelerating the deployment of their AI tools into healthcare, clinical workflows, and life sciences. This move could attract more investor interest in AI companies that are entering regulated markets.

According to the latest disclosures, Anthropic confidentially submitted a draft S-1 registration statement to the U.S. Securities and Exchange Commission (SEC) one week ago, planning to go public. Meanwhile, Reuters reported that OpenAI CEO Sam Altman stated in an internal meeting that the company expects to go public within the next year, with a potential market valuation target of $1 trillion. Neither company has officially confirmed a specific timeline, but the developments mark a new phase in AI commercialization.

In the healthcare sector, these potential IPOs are expected to provide a clearer perspective on how OpenAI and Anthropic are monetizing their AI tools within regulated environments—including hospitals, health systems, payers, clinicians, and pharmaceutical companies. Earlier this year, health tracking ring manufacturer Oura also confidentially filed for an IPO in May, further highlighting the growing capital appeal of digital health and AI convergence.

Bottom line: As OpenAI and Anthropic transition from R&D to public markets, the commercialization path for medical AI will face closer scrutiny. IPOs not only provide these companies with long-term growth capital but may also drive the industry toward more transparent standards for evaluating AI value.